COO vs SNOA · P/E 36, rev $4.09B vs rev $19.5M
The Cooper Companies, Inc (COO) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the COO and SNOA stock pages for the full models.
Not investment advice.